Share on LinkedInShare on LinkedIn

ARTICLE · 19 MARCH 2025

BioZorb And The Power Of Causation: Why Warnings Don't Always Matter

In the ongoing litigation involving the BioZorb device, the U.S. District Court for the District of Massachusetts recently ruled on defendant-manufacturer Hologic's motion for summary judgment in the case of In re BioZorb Device Products Liability Litigation.

United StatesLitigation, Mediation & Arbitration

In the ongoing litigation involving the BioZorb device, the U.S. District Court for the District of Massachusetts recently ruled on defendant-manufacturer Hologic's motion for summary judgment in the case of In re BioZorb Device Products Liability Litigation, No. 22-cv-11895-ADB, 2025 WL 509834, at *4 (D. Mass. Feb. 12, 2025). Plaintiff Pamela Gibson, one of four bellwether trial plaintiffs, alleged that Hologic's failure to adequately warn her breast cancer surgeon about the risks associated with the BioZorb device led to her injuries. Id. at *1. But the court granted partial summary judgment in Hologic's favor, dismissing Gibson's failure-to-warn claim but allowing other claims to proceed. Id. at *4.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from